Catalyst Wire Dossier Catalyst Wire Dossier

Express LD

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Express LD, covering 2008-09-29 to 2008-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries [Phase 3]

See pricing